Cancer News

Cancer News By sherri.place

Web

Images

News

Cancer News >> PHARMACEUTICAL INDUSTRY

November 26, 2009

members login here

Focus Channels

  Cancer
  Genetics
  Biotech
  Pharmaceutical Industry
  Biological sciences

Participate

Build a News Circle

Receive News Briefings

Add this Circle to favorites

Share this News Circle

Subscribe to this News Circle

>>	PHARMACEUTICAL INDUSTRY

(Tentative) Q3 2009 HEI, Inc. Earnings Release - ESTIMATED

Reuters - 2 Hours ago

HEI, Inc. (HEI) operates two business segments that provide a suite of services from design and development, testing to transitional manufacturing and service contract manufacturing. The CompanyÃ¢â?¬â?¢s

(Tentative) Q3 2009 MDI, Inc. Earnings Release - ESTIMATED Reuters

(Tentative) Q3 2008 VIOQUEST PHARMACEUTICALS INC Earnings Release - ESTIMATED Reuters

all 2 news articles >> Add Comment

Luminex Down 13.4% Since SmarTrend's Sell Recommendation

Individual.com - 3 Hours ago

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Luminex (NASDAQ:LMNX) on October 22, 2009 at $16.05. Since then, Luminex has returned 13.4% as of today's recent price of

Array Biopharma Down 32.4% Since SmarTrend's Sell Recommendation Individual.com

Books-A-Million Down 31.9% Since SmarTrend's Sell Recommendation Individual.com

all 112 news articles >> Add Comment

FDA Approves Maraviroc (Selzentry) as First-line Antiretroviral Therapy for Treatment-Naive

HIV and Hepatitis.com - 54 Minutes ago

SUMMARY: The U.S. Food and Drug Administration (FDA) last week approved the first-in-class CCR5 antagonist for use as first-line antiretroviral therapy (ART) for treatment-naive adult HIV patients with

Add Comment

FDA Approves Additional Vaccine for 2009 H1N1 Influenza (Swine Flu)

HIV and Hepatitis.com - 54 Minutes ago

for 2009 H1N1 Influenza Virus The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by

Add Comment

Cyber crime bigger than drug industry

NZCity - 75 Minutes ago

There is a warning cyber criminals will be making an increasingly sophisticated attempt to break in or infect computers in the new year. The warning comes from internet security provider AVG. Spokesman

Add Comment

PharmaceuticalStability.com Announces the Launch of their New Website

PRLog - 83 Minutes ago

PharmaceuticalStability.com is the new website commissioned by two sister companies - Parameter Generation and Control, Inc. FOR IMMEDIATE RELEASE PR Log (Press Release) â?? Nov 26, 2009 â?? PharmaceuticalStability.com

Add Comment

Spectrum Pharmaceuticals and Handok sign collaboration agreement

Individual.com - 75 Minutes ago

Spectrum Pharmaceuticals, a US-based biotechnology company, and Handok Pharmaceuticals, a Korean pharmaceutical company, have announced a collaboration for the development and commercialization of apaziquone

Spectrum collaborates with Handok to develop & commercialize apaziquone in S Korea PharmaBiz

all 1 news articles >> Add Comment

Research shows how anti-cancer drug works

Individual.com - 75 Minutes ago

Researchers at Illinois' Northwestern University said they discovered how the drug tetrathiomolybdate, which is used to fight some metastatic cancers, works. Northwestern said in a release Thursday while

Researchers Optimistic Over New Cancer Pain Drug Pharmaceutical Technology

all 1 news articles >> Add Comment

AstraZeneca Submits US New Drug Application For Ticagrelor (BRILINTA(TM)), An Investigational

MediLexicon - 2 Hours ago

Main Category: / CardiologyAlso Included In: Article Date: 26 Nov 2009 AstraZeneca (NYSE: AZN) announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for

Medical News: AstraZeneca Submits US New Drug Application For Ticagrelor (BRILINTA(TM)), BioFind

all 1 news articles >> Add Comment

Data Miners Can Inform Drug Companies Of Doctors' Prescribing Habits

MediLexicon - 101 Minutes ago

Main Category: / General PracticeAlso Included In: Article Date: 26 Nov 2009 reports: '[P]harmaceutical companies that make prescription drugs are also looking over the doctor's shoulder, keeping track

Medical News: Data Miners Can Inform Drug Companies Of Doctors' Prescribing Habits BioFind

all 1 news articles >> Add Comment

AstraZeneca to move production of raw materials for drugs to China

Times Online - 2 Hours ago

AstraZeneca plans to move all production of the vital molecules in its medicines offshore, mainly to China. The pharmaceuticals companys cost-cutting drive, which will continue for some years, means that

Add Comment

India's Ranbaxy Launches Generic Version Of Valtrex In US ...

Morningstar UK - 4 Hours ago

Morningstar.co.uk membership provides you with expert guidance for making better investment decisions. You'll get access to our in-depth fund research, as well as our portfolio and x-ray tool, investment

Ranbaxy set for Rs 1000 cr boost from Valtrex clone DNA India

Ranbaxy launches generic version of Valtrex in US Livemint.com

all 3 news articles >> Add Comment

S. Korea unlikely to buy problematic H1N1 vaccine from GSK - Zibb...

Zibb - 11 Hours ago

Company: GlaxoSmithKline plc (GSK) South Korea will likely not order a vaccine against the Influenza A (H1N1) virus made by GlaxoSmithKline Plc. (GSK) after the product seemed to have caused a series

S. Korea unlikely to buy problematic H1N1 vaccine from GSK TradingMarkets

all 1 news articles >> Add Comment

ALDA Pharma Inks Deal With Shoppers Drug Mart - Quick Facts

RTTNews.com - 12 Hours ago

Pharma Inks Deal With Shoppers Drug Mart - Optional: Temporarily hide the 'tabber' class so it does not 'flash' on the page as plain HTML. After tabber runs, the class is changed to 'tabberlive' and it

ALDA Enters into Agreement with Shoppers Drug Mart Individual.com

all 1 news articles >> Add Comment

Oceanside Pharmaceuticals launches generic Librax - Zibb.com

Zibb - 16 Hours ago

Company: Valeant Pharmaceuticals International (VRX) Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International, has launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized

Add Comment

Biosante Pharmaceuticals Down 4.8% Since SmarTrend's Sell Recomme...

Zibb - 22 Hours ago

Company: BioSante Pharmaceuticals, Inc. (BPAX) SmarTrend, our proprietary pattern recognition system, called a Downtrend for Biosante Pharmaceuticals (NASDAQ:BPAX) on October 28, 2009 at $1.56. Since

Biosante Pharmaceuticals Down 4.8% Since SmarTrend's Sell Recommendation TMC Net

Cadence Pharmaceuticals Down 12.5% Since SmarTrend's Sell Recomme... Zibb

all 10 news articles >> Add Comment

ISTA Pharmaceuticals, Inc. (ISTA) Corporate Event Announcement No...

Zibb - 23 Hours ago

ISTA Pharmaceuticals, Inc. (ISTA) Expected next earnings release: Announcement date: 2/18/2010 - After Market Earnings Quarter: Q4 Announcement Status: Unconfirmed Expected next investor conference call

Add Comment

Roche seeks broader EU breast cancer label for drug

Reuters Health - 11/26/2009

* EU approval sought for broader Avastin breast cancer use * Application based on study on benefits with chemotherapy ZURICH (Reuters) - Swiss drugmakerRoche Holding has filed for European approval to

Avastin Filed For Broader Breast Cancer Label In Europe For Use In Combination With Pharma Live

UPDATE 1-Roche seeks broader EU breast cancer label for drug Reuters UK

all 2 news articles >> Add Comment

Novartis Shells Out $210M for Two of Incyteâ??s Hematology-Oncology Candidates

Genetic Engineering News - 3 Hours ago

Novartisis paying Incyte Pharmaceuticals $150 million up front and an additional $60 million immediate milestone payment as part of an exclusive licensing deal for two of the latterâ??s clinical-stage

Novartis To Develop, Commercialize Two Hematology-oncology Therapies Of Incyte - RTTNews.com

Incyte to license 2 hematology drugs to Novartis MarketWatch

all 2 news articles >> Add Comment

Clearwire Communications raises $1,057 million through private placement

Individual.com - 3 Hours ago

(Datamonitor Financial Dea) Clearwire Communications, LLC, a US-based provider of internet services, has raised $1,057 million out of a planned $1,564 million private stock offering. Deal Value (US$

Poniard Pharmaceuticals raises $7.45 million in secondary offering Individual.com

Salinas Energy raises $5.27 million through private placement Individual.com

all 14 news articles >> Add Comment

Heska signs supply agreement with Roche Diagnostics

TradingMarkets - 7 Hours ago

- Heska Corporation has signed an agreement with Roche Diagnostics Corp., a division of F. Hoffmann-La Roche, Ltd., for the supply of blood gas products and affiliated consumables for the veterinary market.

Heska Corp signs supply agreement with Roche Diagnostics Individual.com

Heska signs supply agreement with Roche Diagnostics - Zibb.com Zibb

all 4 news articles >> Add Comment

Jubilant partners with US researchers on drug development

Outsourcing Pharma - 8 Hours ago

Indian CRAMS firm Jubilant Organosys has teamed up with the University of Alabama (UAB) and the Southern Research Institute (SRI) to develop affordable treatments for cancer, infection and metabolic disorders.

Add Comment

Ablynx awarded 1.1 M grant; reaches milestone in Novartis collaboration

Science Business - 9 Hours ago

een awarded aworth 1.1 million by the Flemish agency for Innovation by and Technology (IWT). The money will allow the company to accelerate development of alternative routes of administration for its

Add Comment

Merck Serono to invest 150 M in Chinese R&D centre

Science Business - 9 Hours ago

Serono has announced it is to establish a global R&D centre in Beijing,, investing more than 150 million and creating 200 new jobs over the next four years. The centre will specialise in biomarkers, pharmacogenomics

Add Comment

Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for

Bioscience Technology Online - 11 Hours ago

Biological or potency assays are frequently analyzed with the help of the parallel-line or parallel-logistic (4 or 5 parameter fit) methods. These methods have major advantages over traditional single-point

Add Comment



	Already a member? Sign in


	Email Address:
	Password:


Forget your password?

Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms of Use | Privacy Policy | Need Help? | Site Map